companies > N > Natco Pharma Natco Pharma Mylan wins patent battle over sclerosis drug Copaxone 26 August 2016 Natco gets USFDA approval for generic version of Roche’s influenza drug Tamiflu 06 August 2016 Natco, partner settle patent suit over Gilead’s Tamiflu 15 December 2015 Natco to sell generic hepatitis C drug at Rs710 per tablet 12 March 2015 Gilead's patent for hepatitis C drug Sofosbuvir rejected in India 16 January 2015 Natco Pharma opposes Indian patent for Gilead’s hepatitis drug 11 April 2014 Delhi HC bars export of Natco's generic cancer drug on Bayer’s plea 27 March 2014 Bayer appeals against grant of ‘Nexavar’ licence to Natco 07 May 2012 Natco granted compulsory licence for Bayer's Nexavar 12 March 2012 Ministry stays DCGI ban on Natco's generic cancer drug 11 January 2010 Natco Pharma launches H1N1 drug ‘Natflu’ 18 September 2009 Natco, Dr Reddy’s tie up for cancer generics 16 April 2009 Natco Pharma grants global marketing for its generic Copaxone to Mylan 10 June 2008 Natco Pharma acquires 75 per cent in US retail store 31 January 2006 Natco Pharma finalises terms for supply of two onco formulations 20 December 2005 Natco Pharma unveils new drug 26 June 2004  search domain-b    go
Legal Policy | Copyright © 1999-2016 The Information Company Private Limited. All rights reserved.